Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, ...
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
In a podcast first, “Pod Meets World” included the following warning at the top of their latest episode: “This episode ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...
Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
Pancreatic cancer is the third leading cause of cancer-related deaths in the country. The Ramone Foundation is hosting a ...
Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with ...